Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Europäer zahlen zu viel für Pillen

18 July 2017

READ MORE

“É possível fazer os médicos portugueses prescreverem mais genéricos”

18 July 2017

READ MORE

Jacek Glinka: “Biossimilares podem poupar ao SNS 120 milhões de euros”

18 July 2017

READ MORE

Pharma expert: EU drug agency should be ‘easily’ accessible to all

18 July 2017

READ MORE

62% of Medicines Dispensed in Europe are Generic, according to IMS New Data

15 June 2017

Pharmaceutical industry leaders and key stakeholders from the generic, biosimilar […]

Read more

EU Semester Country Specific Recommendations: More Efficient Medicine Policies Needed for Patient Access

23 May 2017

The European Semester Country Specific Recommendations show that healthcare systems […]

Read more

Over 100 Participants Explore Opportunities to Ensure Universal Access to Health

27 April 2017

Over 100 participants explored different ways and opportunities to ensure […]

Read more

Access to Medicines at Sustainable Price: Pharma Industry and Governments Transforming Challenges into Opportunities

23 March 2017

READ MORE

Stimulating Investment in European Generic, Biosimilar and Value Added Medicines through a Transparent Legal Environment

22 March 2017

Key authorities, eminent lawyers and industry leaders discussed today in […]

Read more

Some EU countries effectively delay market entry of generics

17 March 2017

The harmonisation of different regulatory environments in the EU member […]

Read more

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]